Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits
Launched by PORTLAND VA MEDICAL CENTER · Dec 7, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to help veterans who have experienced Major Depressive Disorder (MDD) and are still facing difficulties with thinking, memory, and attention even after their depression has improved. The study will test a program called Motivationally Enhanced Compensatory Cognitive Training (ME-CCT-MDD) over eight weeks, comparing it to a supportive contact group that focuses on setting and achieving personal goals. The goal is to see if the cognitive training can help improve cognitive skills, mental health, and overall quality of life for these veterans.
To participate, veterans must be between 18 and 65 years old, have received treatment for MDD in the past year, and report ongoing problems with cognitive functioning. Participants will undergo an assessment to understand their cognitive abilities and symptoms, and then they will be randomly assigned to one of the two treatment groups, attending weekly sessions for two hours each time. After eight weeks, they will complete another assessment to see how their symptoms have changed and share their experiences. This study is important because it aims to find effective ways to support veterans who continue to struggle with cognitive issues after treatment for depression.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Veterans 18 years of age or older
- • 2. Self-reported concerns about cognitive functioning deficits or clinical concerns about cognitive functioning deficits documented in EHR
- • 3. meets DSM-5 criteria for MDD and receiving treatment for this diagnosis at the Portland VA within the past year
- • 4. moderate or greater depressive symptoms as assessed by a PHQ-9 score ≥ 10
- • 5. current cognitive functioning deficits as determined by performance on at least two measures in one cognitive domain (i.e., memory, attention/processing speed, language, executive functioning) falling ≥1 SD below their age-appropriate norms in the absence of memory impairment.
- Exclusion Criteria:
- • 1. impaired capacity to understand study risks and benefits
- • 2. history of TBI as defined by American College of Rehabilitation Medicine and VA/DoD criteria
- • 3. meets DSM-5 criteria for a substance use disorder other than nicotine use disorder in the past 6 months
- • 4. meets DSM-5 criteria for dementia, psychotic disorder, or "with psychotic features" specifier
- • 5. active suicidal intent with significant clinical risk
- • 6. auditory or visual impairments that would prevent ability to participate in cognitive rehabilitation group or assessments. Eligibility will be established by electronic medical record review conducted by study staff and will be confirmed by the Veteran during the initial phone call.
About Portland Va Medical Center
The Portland VA Medical Center is a leading clinical research institution dedicated to advancing healthcare for veterans through innovative research and clinical trials. As part of the U.S. Department of Veterans Affairs, the center focuses on a wide array of medical disciplines, including mental health, rehabilitation, and chronic disease management. With a commitment to improving patient outcomes, the Portland VA Medical Center engages in rigorous scientific inquiry while prioritizing the well-being and needs of veteran populations. Its collaborative environment fosters partnerships with academic institutions and healthcare organizations, ensuring that research findings translate into effective treatments and improved quality of care for those who have served in the armed forces.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Oregon, United States
Patients applied
Trial Officials
Maya O'Neil, PhD
Principal Investigator
Portland VA Medical Center
Joren Adams
Principal Investigator
Portland VA Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported